Caricamento...

Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants

Spontaneous mutants of susceptible clinical and laboratory isolates of Streptococcus pneumoniae exhibiting reduced susceptibility to evernimicin (SCH27899; MIC, 0.5 to 4.0 mg/liter) were selected on plates containing evernimicin. Four isolates that did not harbor mutations in rplP (which encodes rib...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Adrian, Peter V., Mendrick, Cara, Loebenberg, David, McNicholas, Paul, Shaw, Karen J., Klugman, Keith P., Hare, Roberta S., Black, Todd A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2000
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC101610/
https://ncbi.nlm.nih.gov/pubmed/11036030
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !